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It has been suggested that dietary estrogens neutralize the effect of synthetic chemicals that
mimic the effects of estrogen (i.e., xenoestrogens, environmental estrogens). Genistein, a dietary
estrogen, inhibits the growth of breast cancer cells at high doses but additional studies have
suggested that at low doses, genistein stimulates proliferation of breast cancer cells. Therefore, if
dietary estrogens are estrogenic at low doses, one would predict that they stimulate estrogen-
receptor positive breast cancer cells to enter the cell cycle. Genistein and the fungal toxin
zearalenone were found to increase the activity of cyclin dependent kinase 2 (Cdk2) and cyclin D1
synthesis and stimulate the hyperphosphorylation of the retinoblastoma susceptibility gene
product pRb105 in MCF-7 cells. The steroidal antiestrogen ICI 182,780 suppressed dietary
estrogen-mediated activation of Cdk2. Dietary estrogens not only failed to suppress DDT-induced
Cdk2 activity, but were found to slightly increase enzyme activity. Both zearalenone and genistein
were found to stimulate the expression of a luciferase reporter gene under the control of an
estrogen response element in MVLN cells. Our findings are consistent with a conclusion that
dietary estrogens at low concentrations do not act as antiestrogens, but act like DDT and
estradiol to stimulate human breast cancer cells to enter the cell cycle. Environ Health
Perspect 105(Suppl 3):633-636 (1997)
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Estrogenic chemicals present in the human
diet or environment have been called
xenoestrogens or environmental estrogens.
Recently it has been suggested that xeno-
estrogens may have a role in the etiology of
breast cancer (1,2,3). Compounds that
have been suggested to be xenoestrogens
include pesticides, dyes, pollutants, plasti-
cizers and food preservatives (2,4-7). For
example, the pesticide DDT and the food
colorant Red Dye No. 3 have been shown
to bind to the estrogen receptor (ER) and
to stimulate proliferation of ER-positive
breast cancer cells (2). At the molecular
level, DDT and Red Dye No. 3 mimic the
effects of estradiol by stimulating breast
cancer cells to enter the cell cycle (2,8).
Entry into the cell cycle requires cyclin D1
synthesis, activation of cyclin-dependent
kinase 2 (Cdk2), and retinoblastoma pro-
tein (pRblO5) hyperphosphorylation (2,8).
Phosphorylation of pRb105 by activated
cyclin-dependent kinase can be detected as
a migration shift using Western blot analy-
ses after breast cancer cells are treated with
estradiol, Red Dye No. 3, or DDT (8-11).
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Whether xenoestrogens have a role in the
etiology of human breast cancer remains
controversial (1,12-16). It has been sug-
gested that exposure to xenoestrogens cannot
produce adverse effects on reproductive tis-
sue because they are neutralized by estro-
genic compounds derived from dietary
sources (17). Therefore, if dietary estro-
gens have chemopreventive activity by
antagonizing the effects of estrogen, one
would predict that cellular processes associ-
ated with entry into the cell cycle (e.g.,
cyclin-dependent kinase activation, cyclin
DI synthesis) would be blocked by dietary
estrogens. Genistein has recently been
shown to be a potent inhibitor of ER-
positive breast cancer cell growth when
added at high concentration (> 10 pM)
(18,19). However, genistein at lower con-
centrations has also been shown to increase
the growth ofER-positive cells (19,20).
In this study, we examined the effects
ofdietary estrogens on cyclin D1 synthesis,
Cdk2 activity, and pRb1O5 phospho-
rylation. By performing Cdk2 assays on
MCF-7 breast cancer cells that were treated
with low concentrations of genistein or
zearalenone in addition to DDT, we also
determined if genistein or zearalenone
exhibited antiestrogenic activity. The abil-
ity ofzearalenone and genistein to stimu-
late the expression ofa reporter gene under
the control ofan estrogen response element
in human breast cells stably transfected
with this construct was also determined.
Materials and Methods
Chemicals
ICI 182,780 was a gift from Alan Wakeling,
Zeneca Pharmaceuticals (Macclesfield,
England). Dietary estrogens and estradiol
were purchased from Sigma Chemicals (St.
Louis, MO). Dietary estrogens and DDT
were concentrated solutions in absolute
ethanol. An equal amount ofethanol was
added to all control cells.
Human Breast CancerCells
MCF-7 cells were maintained in Dulbecco's
Modified Minimal essential medium/
Hams F12 1:1 without phenol red (Sigma
Chemicals). Both cell lines were incubated
at 37°C in a 5% CO2 atmosphere with
10% fetal bovine serum (FBS). Prior to
studies on Cdk2 activation, MCF-7 cells
were growth arrested by removal of serum
and transfer into methionine-free medium
for 72 hr before exposure. During dietary
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estrogen exposure, breast cells were
maintained in methionine-containing
DMEM/F12 (phenol red- and FBS-free).
MVLN cells were provided by M.J.
Duchesne, Montpelier, France. These cells
have been stably transfected with a firefly-
luciferase reporter gene that is under the
control ofan estrogen response element of
the Xenopus vitellogenin A2 gene and a
thymidine kinase promoter ofthe Herpes
simplex virus (21).
EstgnicityAssay
The ability ofzearalenone and genistein to
stimulate the expression ofluciferase pro-
duction under the control of an estrogen
response element was performed by depriv-
ing MVLN cells of estrogen. Estrogen
deprivation in MVLN cells was accom-
plished by growing them in culture with
phenol red-free DMEM/F12 medium con-
taining 5% charcoal-stripped, delipidated
calfserum. After gradual withdrawal ofthe
serum, the cells were left in the medium
alone for 24 hr more and then treated with
estradiol (1 nM), estradiol (1 nM) and ICI
182,780 (100 nM), zearalenone (10 nM),
zearalenone (10 nM) and ICI 182,780
(100 nM), genistein (0.1 pM), or genistein
(0.1 pM) and ICI 182,780 (50 nM). The
medium alone was used as the control.
After 24 hr of treatment the cells were
lysed and the luciferase assay performed
using Promega's Luciferase Assay kit
(Madison, WI) per the kit protocol. Light
emission from treated MVLN cell extracts
was measured using a scintillation counter
in out-of-coincidence mode.
Cyclin-dependent Kinase 2Assays
MCF-7 cells for Cdk2 analysis were
exposed to estrogens for 20 hr. After incu-
bation, cells were washed twice with ice-
cold phosphate-buffered saline (PBS) and
lysed by the addition of cold lysis buffer
(Tris 20 mM, pH 7.5, NaCl 250 mM,
0.1% NP-40, NaF 10 mM, NaVO3
1 mM, PMSF 1 mM). After 15 min on ice,
the lysates were centrifuged at 20,000x g
for 15 min (40C). Cdk2 was precipitated
from equal amounts of cell extracts using
purified rabbit anti-Cdk2 (Santa Cruz
Biotechnology, Santa Cruz, CA) and pro-
tein albumin-globulin (A/G) agarose.
Immunoprecipitates were washed three
times with the lysis buffer and twice with
kinase buffer (Tris 40 mM, pH 7.5, MgCl2
10 mM). The immunoprecipitates were
suspended in 30 pl ofkinase buffer supple-
mented with 400 pg/mi histones (Sigma
Chemicals type II-SS), 5 pM adenosine
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Figure 1. Genistein (0.1 pM) and zearalenone (10 nM) at lowconcentrations mimic effects ofestradiol by stimulating
luciferase production in MVLN cells where the reporter gene is underthe control ofan estrogen-response element.
The steroidal antiestrogen ICI 182,780(100 nM) blocks genistein- and zearalenone-stimulated luciferase production.
triphosphate (ATP), 0.5 mM dithiothreitol,
0.5 mM ethylene glycol tetraacetic acid,
and 5 pCi -[32P]-ATP for 20 min at room
temperature. The reaction was stopped
using gel electrophoresis sample buffer, and
the reaction products were separated on a
14% polyacrylamide gel (Novex, San
Diego, CA).
CyclinD1 Synthesis
MCF-7 cells were plated in six well culture
plates, grown to 60 to 80% confluency, and
growth arrested as described for kinase
assays. Deficient medium was replaced and
the dietary estrogens added as indicated. At
appropriate time points, medium in wells
to be radiolabeled was changed to methion-
ine-free DMEM/F12 (no serum or phenol
red). After 15 min at 37°C, this mediumwas
removed and replaced with methionine-free
DMEM/F12 containing 50 pCi ofTrans
35S-label (1000 Ci/mmol). Following incu-
bation for 2 hr at 370C, labeling medium
was removed and the monolayers were
washed twice with ice-cold PBS. Lysates
were prepared as given for kinase assays and
stored at -800C for later use. For immuno-
precipitation analysis, lysates were equalized
based on protein concentration and pre-
cleared with 30 pl ofprotein A/G agarose
beads followed by incubation with antibod-
ies to cyclin D1 (mab HD-11, Santa Cruz
Biologicals, Santa Cruz, CA), 1 pg per sam-
ple, and protein A/G agarose beads. After
18 hr at 4°C, immune precipitates were
washed 5 times with wash solution, sus-
pended in IX sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis sample
buffer, boiled, and separated on 12% poly-
acrylamide gels. Following electrophoresis,
the gels were fixed, washed in water, and
soaked in 1 M sodium salicylate (pH 6.0)
before drying. Fluorography was performed
using KodakXARfilm at-800C.
Results
Stimulation ofEstrogen Recptor-
controlledLucieraseProduction
We hypothesized that ifdietary estrogen
exposures were mitogenic, they acted
through the ER. Therefore, the expression
of a reporter gene (luciferase) under the
control of an estrogen response element
must be increased in MVLN cells exposed
to dietary estrogens. (Figure 1) shows that
exposure ofMVLN cells to genistein (0.1
pM) or zearalenone (10 nM) stimulates the
production of a luciferase reporter gene
that is under the control of aXenopus estro-
gen response element. The steroidal antie-
strogen ICI, 182,780 (100 nM) inhibited
luciferase production in MVLN cells stimu-
lated by all ofthe estrogens, demonstrating
the requirement for ER in xenoestrogen
action (Figure 1).
Stimulation ofCydin D1 Synthesis
Synthesis ofcyclin D1 occurs early in G1
phase prior to activation ofCdk2 (9-11).
Estradiol and xenoestrogens (e.g., DDT,
Red Dye No. 3) (2) induce increased syn-
thesis ofcyclin D1 in G1-arrested MCF-7
cells (8). Increased synthesis ofcyclin D1
protein induced by genistein and zear-
alenone confirm that both dietary estrogens
regulate expression of this protein critical
for progression through the cell cycle at low
concentration (0.5 pM) (Figure 2).
CyclinD1 .11_' 1_
Time, hr 9 12 9 12
9 12
9 12
Figure 2. Increased cyclin D, synthesis is found in
MCF-7 cells treated with genistein or zearalenone at
lowconcentrations (0.5 pM).
Environmental Health Perspectives * Vol 105, Supplement 3 * April 1997 634DIETARY ESTROGENS STIMULATE CELL CYCLE ENTRY
B
I* HHI
20 hr
Figure 3. (A) Genistein and zearalenone increase Cdk2 activity in MCF-7 breast carcinoma cells; (B) increased
activity in Cdk2 activity in genistein-treated (1 pM) and zearalenone-treated (1 nM) MCF-7 cells was completely
inhibited by the steroidal antiestrogen ICI 182,780 (50 nM). Cdk2 activity stimulated by DDT (0.3 pM) was also
completely inhibited by ICI 182,780 (50 nM). However, the same concentration of ICI 182,780 only partially
suppresses Cdk2 activation stimulated by estradiol (10 nM).
StimulationofCdk2Activation
Subsequent to cyclin DI synthesis and
activation ofCdk4, transit ofcells through
G1 and entry into S phase requires Cdk2
activation (9-11). Both genistein and zear-
alenone stimulated Cdk2 activity when
added to growth-arrested MCF-7 cells
(Figure 3A). Increased Cdk2 activity
induced by genistein or zearalenone could
be detected as early as 12 to 16 hr after
they were added to MCF-7 cells (data not
shown). However, maximum levels of
dietary estrogen-stimulated Cdk2 activity
occurred 18 to 22 hr after they were added
to human breast cancer cells (Figure 3A).
The steroidal antiestrogen ICI 182,780
(50 nM) partially inhibits Cdk2 activation
stimulated by estradiol (10 nM) and com-
pletely inhibits Cdk2 activation by DDT
(0.3 pM), genistein (1 pM), and zear-
alenone (1 nM) (Figure 3B). Both genis-
tein and zearalenone slightly increased
Cdk2 activity induced in MCF-7 cells by
DDT (Figure 4).
Phosphoylation ofpRblO5
Cdk activation results in the hyperphos-
phorylation and inactivation of pRbIO5,
allowing for release oftranscription factors
9%°#°8 X~~~~~
20 hr
Figure 4. Cdk2 activity in MCF-7 cells is
DDT, genistein, and zearalenone. Wher
low concentrations of DDT, genistein and
increase the Cdk2 activity above that prod
genistein, orzearalenone alone.
I,*-HH1
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n added with
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luced by DDT,
ofthe E2F family, which are required for S
phase entrance (10). Therefore, ifdietary
estrogens mimic the effects ofestradiol on
the cell cycle, then increased phosphoryla-
tion of pRblO5 should occur in breast
cancer cells treated with dietary estrogens.
Figure 5 shows that low levels of dietary
estrogens (0.5 pM) induce hyperphospho-
rylation ofpRblO5 that can be detected as
a mobility shifted form of pRblO5 by
Western blot analyses.
Discussion
The role, if any, that xenoestrogens have
in the etiology ofhuman breast cancer is
controversial (1,2,15,17,22). Some investi-
gators have proposed that exposure to
xenoestrogens may enhance the risk of
developing breast cancer (1,2,22). Some
epidemiologic studies have supported this
hypothesis (3), but others do not find any
correlation with xenoestrogen exposure and
breast cancer (14). Additionally, it has been
proposed that exposure to estrogenic chem-
icals in the diet may neutralize or somehow
prevent xenoestrogens from having any
significant biologic effect (17).
Human diets contain plant-derived
nonsteroidal estrogenic compounds (e.g.,
genistein). Other estrogenic molecules in
the diet may include compounds produced
by fungi (e.g., zearalenone) (20). Additional
estrogenic compounds in the diet may
i _ _ pRb1O5-P pRb1O_5
20hr
Figure 5. Genistein and zearalenone induce hyper-
phosphorylation of pRbl05. Hyperphosphorylated
pRblO5 is evident as a slower migrating band.
include zeranol, a synthetic derivative of
zearalenone, which has been used as a hor-
monal growth-promoter in cattle (20).
Dietary derived estrogenic compounds like
genistein have been proposed to act in pre-
venting proliferation of ER-positive breast
cells (17). However, one previous report
failed to find any chemopreventive action
ofgenistein or zearalenone because these
compounds stimulated the growth of
MCF-7 human breast cancer cells (20).
More recent reports suggest that genistein
is a potent inhibitor of MCF-7 cells
(18,19). The apparent disparity in the
reported effects of genistein on MCF-7
cells may depend on the concentration of
genistein used. Genistein is a potent
inhibitor of protein tyrosine kinases and
can inhibit cell cycle progression in tumor
cells independent of action at the ER
(23,24). Other inhibitors ofMCF-7 cells
have been shown to have concentration-
dependent estrogenic effects and can also
display antiestrogenic activity (25). We
surmised that dietary estrogens may have
estrogenic activity at low concentrations
and antiestrogenic activity or toxicity at
higher concentrations.
It has been previously demonstrated
that estrogen induces Cdk2 activity, cyclin
D1 synthesis, and hyperphosphorylation of
pRb105 in growth-arrested MCF-7 cells
(8). Two xenoestrogens also have been
shown to mimic estrogen's ability to stimu-
late MCF-7 cells to enter the cell cycle (2).
Therefore, using Cdk2 activation, cyclin D1
synthesis, and hyperphosphorylation of
pRb105, we examined the effects of low
concentrations ofgenistein and zearalenone
on growth-arrested MCF-7 cells.
In all assays the dietary estrogens simu-
lated molecular changes, indicating that
theystimulated cell cycle entry. Additionally,
rather than antagonizing the effects of
DDT, both dietary estrogens stimulated
Cdk2 activation. Hyperphosphorylation of
pRblO5 was induced by both genistein and
zearalenone. Flow cytometric data has con-
firmed that both genistein and zearalenone
induce Sphase entry in MCF-7 cells as has
been demonstrated with estradiol (8) (data
not shown). Therefore, at low concentra-
tions, dietary estrogens appear to stimulate
MCF-7 cells to enter the cell cycle. In addi-
tion, the steroidal antiestrogen ICI 182,780
was found to inhibit stimulation ofCdk2
activity by genistein and zearalenone (Figure
3B). Genistein and zearalenone also stimu-
lated the production ofa reporter molecule
under the control ofan estrogen response
element that was also inhibited by ICI
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182,780 (Figure 1). Therefore, genistein
and zearalenone stimulation of human
breast cancer cells to enter the cell cycle is
mediated through the dietary estrogens'
effects on the ERand transcriptional control
via estrogen-responsive elements. Further
studies are required to determine ifgenistein
and zearalenone inhibit Cdk2 activity,
cyclin D1 synthesis, and hyperphosphoryla-
tion ofpRblO5 athigher concentrations.
Our studies using molecular assays to
evaluate the effects of dietary estrogens
agree with previous reports (19,20) that at
low concentrations, genistein and zeara-
lenone produce proliferative effects on
human breast cancercells. Theeffects appear
to be concentration dependent, which
would agree with a recent study that shows
stimulation ofMCF-7 cell growth at genis-
tein concentrations ofless than 10 pM.
Our studies do not support the suggestion
that dietary estrogens neutralize the effects
of DDT. In contrast, the effects ofdietary
estrogens at low concentrations on DDT-
induced Cdk2 activation appear to be
additive orperhaps synergistic (Figure 4).
Under the proper conditions and con-
centrations, genistein has been reported to
be a potent inhibitor ofMCF-7 cell growth
(18,19). However, our studies suggest that
women should not consume particular
foods (e.g., soy-derived products) to pre-
vent breast cancer. Further, our results sug-
gest that low concentrations ofgenistein
may stimulate MCF-7 cells to enter the cell
cycle. Ifthe amount of estrogens that can
be derived from the dietary sources does
not contribute a level high enough to sup-
press ER-positive cell growth, dietary estro-
gens may increase the risk ofbreast cancer,
especially in combination with dietary
derived xenoestrogens. The risk ofexposure
to xenoestrogens and low levels ofdietary
estrogens may be further increased ifdevel-
oping fetal tissues are exposed (23).
The molecular effects ofdietary derived
and xenoestrogens on ER-positive breast
cancer cells appear to be complex. The effects
ofdietary estrogens may be concentration
dependent and may ilteract with synthetic
and natural estrogens. It may be premature
at this time to suggest dietary changes that
significantly alter the amount of dietary
derived estrogens until additional research
can fully elucidate the effects they have on
reproductive tissues in terms ofdose, tis-
sue-specific effects (like tamoxifen), and
potential interactions with other estrogenic
compounds. It remains to be determined if
dietary estrogens are beneficial or, as sug-
gested by our in vitro studies, an additional
carcinogenic risk factor for tissues where
proliferation is controlled by estrogens.
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